leukemia research case report

About the journal. Official journal of the Myelodysplastic Syndromes Foundation . Leukemia Research Reports (LRR), a companion title to Leukemia Research, is a peer-reviewed publication devoted to the rapid publication of short, high-quality papers related to a broad scope of therapeutic areas of hematology, …. View full aims & scope.

Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of ...

All articles published in Leukemia Research Reports are peer-reviewed and indexed in PubMed/PubMed Central and Scopus. They are fully citable through digital object identifiers (DOI) and rapidly available online via ScienceDirect, the world's leading online content platform. ... Case Reports must present an abstract, should not exceed 1,500 ...

Relapsed acute myeloid leukemia. Discussion of Management. Dr. Andrew M. Brunner: This 49-year-old man had a subtype of AML that had arisen de novo, with a normal male karyotype and mutations in ...

Read the latest Research articles from Leukemia. ... Case Report (2) Debate Round Table (53) ... 8-Cl-Ado and 8-NH 2-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute ...

Posted: December 10, 2019. For children and young adults with certain relapsed B-cell acute lymphoblastic leukemia (B-ALL), the immunotherapy drug blinatumomab is superior to standard chemotherapy, an NCI-sponsored Children's Oncology Group trial shows. Gilteritinib Improves Survival in AML with FLT3 Mutations.

Translocation (2;8) (p12;q24) in blastic transformation of atypical chronic myeloid leukemia. SK Ma. KL Au. LC Chan. Case Report 01 Apr 1997. Leukemia ( Leukemia) ISSN 1476-5551 (online) ISSN 0887 ...

The phase 1-2 HGB-206 study is evaluating the efficacy and safety of LentiGlobin for sickle cell disease, and an unprespecified interim analysis of the results is now reported in the Journal. 8 ...

Leukemia (2024) Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML) is occurring rapidly. Since 2017, nine agents have been approved for various indications in ...

Clinically, both acute myelocytic leukemia (AML) and T-lymphoblastic lymphoma (T-LBL) are common hematological malignancies. 1,2 Because AML and T-LBL have different cell origins, their onsets are usually isolated, and it is rare for both diseases to develop concurrently in the same patient. 3,4 We report an AML patient complicated with T-LBL, and we describe the patient's disease evolution ...

INTRODUCTION. Congenital leukemia (CL) accounts for < 1% of all the reported cases of pediatric leukemia and is often manifested during the first 28 d of life[].CL is the third-most prevalent malignancy in infants after teratoma and neuroblastoma[].The estimated frequency of newborn leukemia in the United Kingdom is 3 cases per million newborns with about 2 cases of newborn leukemia reported ...

This is the second case report to report the use of daratumumab in plasma cell leukemia. More research is needed in exploring genomic variations which may potentially identify various novel biomarkers that may serve as prognostic markers. Overall clinical course remains poor, signaling a need for more agents, and effective management strategies.

1. Introduction. Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm driven by t(9;22) BCR/ABL1 fusion, and patients typically present with granulocytosis and no evidence of dysplasia. Tyrosine kinase inhibitor (TKI, including first-generation imatinib; second-generation nilotinib, dasatinib, and bosutinib; and third-generation ponatinib) has been the mainstream therapy for the ...

Discussion. The incidence of acute leukemia is approximately 2.3 per 100000 people per year.AML M-7 is a rare subtype of leukemia and represents 1.2% of cases of adult leukemia, compared to 3-10% of childhood leukemia ( 10 ).It is classified under M-7 in the French-American-British classification ( 11 ). The patient was a 26 month years old ...

Characteristics and survival outcomes of patients with atypical chronic myeloid leukemia in the United States: A SEER-based analysis. Nosakhare Paul Ilerhunmwuwa, Mustafa Wasifuddin, Henry Becerra, Aditya Keerthi Rayapureddy, Jen Chin Wang. Article 100383. View PDF.

In a. review of outcomes of 8 patients with AUL after allogenic HSCT, median. overall survival at 1 year was 37.5% (95% CI, 9.9% -65.9%). Conclusion: AUL is a rare hematological malignancy with ...

cutaneous involvement in hematologic malignancies: report of six cases with high mortality rate. An Bras Dermatol. 2018, 93:726-729. 7. Arikan S, Lozano-Chiu M, Paetznick V, Rex JH: In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob Agents Chemother. 2002, 46:245-247. 10.1128/AAC.46.1.245-247.2002

Acute lymphoblastic leukemia (ALL) is the most common form of childhood cancer, and it usually is curable. However, patients who experience relapse have lower odds of survival. In a new case ...

Leukemia is one of the leading journals in hematology and oncology. It covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered ...

Scope Leukemia Research Reports (LRR), a companion title to Leukemia Research, is a peer-reviewed publication devoted to the rapid publication of short, high-quality papers related to a broad scope of therapeutic areas of hematology, including hematologic malignancies and other non-malignant diseases, such as: • Hematopoetic and stem cell transplantation; • Marrow and stem cell ...

Lenalidomide induced secondary Acute Lymphoblastic Leukemia in a Multiple Myeloma patient: A case-report. Dr. Saqib Raza Khan, Dr. Muhammad Tariq, Dr. Sidra Malik Fayyaz, Salman Muhammad Soomar, Dr. Munira Moosajee. Article 100315. View PDF.

Contacts. ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office ...

Leukemia Research Reports is an open access, international journal which delivers timely information online to all health care professionals involved in basic and/or applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies. It does this by rapidly publishing a range of peer-reviewed short form papers, including brief communications, case reports ...

The benefits of denosumab as an antiresorptive therapy and in reducing fragility fractures are well documented. However, its association with atypical femur fractures (AFFs), especially in the absence of prior bisphosphonate use, remains poorly understood and warrants further investigation. This case report presents a rare instance of bilateral AFFs in a 78-year-old bisphosphonate-naïve ...

Summary. Job seekers worry about negotiating an offer for many reasons, including the worst-case scenario that the offer will be rescinded. Across a series of seven studies, researchers found that ...

Case report Open access Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation. ... (BNT162b2): A single-institution retrospective experience' Leukemia research reports 18C (100,342)

Tissue-invasive cytomegalovirus (CMV) disease represents a well-recognized complication after kidney transplantation. However, direct involvement of the urogenital tract and CMV-ureteritis occur less frequently. Nephrogenic adenomas are benign lesions of the urinary tract preferentially reported in kidney transplant recipients. We herein report a second case of a 33-year-old male kidney ...